Publications by authors named "Tacila Pires Mega"
Rev Saude Publica
August 2023
Article Synopsis
- This study analyzes the costs and usage of biological drugs for rheumatoid arthritis treatment within Brazil's public health system (SUS) from 2012 to 2017.
- It examines secondary data on drug purchases, patient numbers, and spending, focusing on specific drugs most frequently utilized.
- Results show significant investments of around $500 million, with adalimumab and etanercept being the most costly, while highlighting a 33% increase in patients treated with biological drugs. *
